Facebooktwittergoogle_pluspinterestlinkedin

The InMotion Musculoskeletal Institute and Active Implants Corporation (AIC) announced today a new research partnership focused on total joint implants utilizing compliance, polymeric materials. This new collaboration extends Active Implant’s already robust research programs to provide next generation orthopedic implant solutions that will benefit patients worldwide.

AIC’s novel technology employs biocompatible materials that mimic aspects of natural cartilage in its management of biomechanical joint forces. InMotion’s involvement will give Active Implants a local research partner. “We are excited to have excellent research capabilities like InMotion right here in Memphis,” said Richard Treharne, PhD, Vice President, Orthopedic Research for AIC.

InMotion will perform independent, contract research in each of its core science areas, including biologics & biomaterials, biomechanics, and clinical research. Involved in the projects will be InMotion’s 19 science professionals, including four PhD-level researchers, MD and MD/PhD level clinician scientists, and three RN-level researchers, along with associated staff.

“InMotion is a welcome addition to our accomplished research group that includes Duke University, Leeds University, University of Tennessee, and Case Western as well as with our internal research team,” added Stephen Bradshaw, President & CEO of Active Implants. “We think they will complement our current assets.”

According to Dick Tarr, President & Executive Director at InMotion, this type of partnership is integral to growing biotechnology in Memphis. “InMotion has a lot of capabilities to offer,” Tarr says. “Were delighted to help our business partners perform research that could fundamentally change quality of care for millions of patients suffering from musculoskeletal pain and diseases.”

Active Implants Corporation is a privately held company formed four years ago by experienced orthopedic executives and an inventor with vast knowledge in the field of advanced polymers. AIC’s  intellectual property contains innovative implant solutions and minimally invasive surgery technology with applications in the joints and spine. AIC is commercializing its first product in Europe, the TriboFit® Hip System. The company is headquartered in Memphis, Tennessee, with research facilities in Netanya, Israel.

InMotion’s mission is to improve mobility and reduce disability for the musculoskeletal patient through translational research. The company is headquartered in Memphis, Tennessee.